| Oral Riboflavin to Assess Ureteral Patency During Cystoscopy: A Randomized Clinical Trial 2019 · riboflavin group · Women scheduled for gynecologic surgery with cystoscopy planned | 400 mg | 1 day | 33 |
| Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial 2009 · Placebo · Adults aged 18–55 with cocaine dependence and recent cocaine use | 100 mg | 8 weeks | 27 |
| Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets 2010 · Levodopa/carbidopa with CM-ATTEND · Adults with current cocaine dependence and recent self-reported cocaine use; mostly male; mean age 41 years | 100 mg | 12 weeks | — |
| Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets 2010 · Levodopa/carbidopa with CM-MEDICATION · Adults with current cocaine dependence and recent self-reported cocaine use; mostly male; mean age 41 years | 100 mg | 12 weeks | — |
| Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets 2010 · Levodopa/carbidopa with CM-URINE · Adults with current cocaine dependence and recent self-reported cocaine use; mostly male; mean age 41 years | 100 mg | 12 weeks | — |
| Urine staining intensity and observation of intraoperative ureteral jets among oral agents 2022 · riboflavin · Adults undergoing surgery with cystoscopy; age range and condition not specified | 400 mg | 1 day | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · riboflavin · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 11.4 mg | 87 weeks | — |
| Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial 2009 · Immediate-release methamphetamine · Adults aged 18–55 with cocaine dependence and recent cocaine use | 100 mg | 8 weeks | 30 |
| Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial 2009 · Sustained-release methamphetamine · Adults aged 18–55 with cocaine dependence and recent cocaine use | 100 mg | 8 weeks | 25 |
| Impact of Vitamin B1 and Vitamin B2 Supplementation on Anxiety, Stress, and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial 2025 · vitamin B1 and vitamin B2 nutritional supplementation group · Volunteers aged 18–25 years with elevated anxiety, perceived stress, poor sleep scores, and deficient vitamin B1 and B2 status | 100 mg | 4 weeks | 25 |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · 20 mg iron and 20 mg zinc with 1 mg riboflavin · Infants aged 6 months at enrollment, followed until 12 months | 143 mcg | 183 days | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · Micronutrient mix (MM) · Infants aged 6 months at enrollment, followed until 12 months | 143 mcg | 183 days | — |
| Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform 2008 · Levodopa + ClinMan · Adults with current cocaine dependence and recent cocaine use | 100 mg | 12 weeks | — |
| Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform 2008 · Levodopa + CBT · Adults with current cocaine dependence and recent cocaine use | 100 mg | 12 weeks | — |
| Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform 2008 · Levodopa + VBRT · Adults with current cocaine dependence and recent cocaine use | 100 mg | 12 weeks | — |
| Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supplement 1994 · riboflavin group · Rural Gambian children aged 8–14 years, preselected for the study; endemic riboflavin deficiency was reported | 5 mg | 1 year | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 1.6 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 1.8 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 20 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women | 20 mg | — | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 11.4 mg | 87 weeks | — |
| Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial 2015 · Verum (investigational nutritional product) · Adults aged 18–65 of either sex with migraine with or without aura, and at least 3 migraine attacks per month before recruitment | 400 mg | 90 days | 63 |
| Effectiveness of zinc supplementation to full term normal infants: a community based double blind, randomized, controlled, clinical trial 2013 · Zinc · Full-term, healthy infants from a low-income urban community in India, supplemented from 4 to 18 months of age | 500 mcg | 360 days | 163 |
| A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial 2004 · active combination · Patients with migraine; age and sex not reported | 400 mg | 90 days | — |
| Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction 1992 · active vitamin group · Geriatric inpatients with depression and cognitive dysfunction | 10 mg | 4 weeks | — |
| Supplementation with iron and riboflavin enhances dark adaptation response to vitamin A-fortified rice in iron-deficient, pregnant, nightblind Nepali women 2007 · FeR + VA · Pregnant Nepali women with nightblindness; the reported pupillary-threshold subgroup was iron-deficient at baseline | 6 mg | 6 weeks | — |
| Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up 2012 · riboflavin intervention · Patients with cardiovascular disease and the MTHFR 677TT genotype | 1.6 mg | 16 weeks | 31 |
| Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial 2013 · riboflavin · Hypertensive individuals with the MTHFR 677TT genotype and no overt cardiovascular disease; age and sex not reported | 1.6 mg | 16 weeks | — |
| Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER) 2022 · Experimental group (SINR) · Men and women aged 45–74 with type 2 diabetes and symptomatic distal sensorimotor diabetic polyneuropathy | 10 mg | 85 days | 108 |
| Effect of zinc plus multivitamin supplementation on growth in school children 2016 · Chelated zinc plus multivitamins · Healthy Thai schoolchildren aged 4–13 years | 3 mg | 26 weeks | 70 |
| A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial 2023 · Ex PLUS® group · Healthy male and female non-athletes aged 20–30 | 10 mg | 4 weeks | 32 |
| Randomized, double-blind, placebo-controlled study of the safety and efficacy of vitamin B complex in the treatment of nocturnal leg cramps in elderly patients with hypertension 1998 · vitamin B capsules · Elderly patients with hypertension and severe nocturnal leg cramps | 15 mg | 90 days | 14 |
| Effects of vitamin-B complex supplementation on periodontal wound healing 2005 · Vit-B · Adults with generalized moderate to severe chronic periodontitis undergoing access flap surgery; ages not reported; 13 males and 17 females enrolled across the study | 50 mg | 30 days | — |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 10 mg | 120 days | — |
| Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance 2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking | 1.1 mg | 90 days | — |
| Riboflavin Supplementation Promotes Butyrate Production in the Absence of Gross Compositional Changes in the Gut Microbiota 2023 · Ribo100 · Healthy adults aged 18–60 years, male and female, with BMI 18–25 kg/m² | 100 mg | 2 weeks | 33 |
| Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans 1996 · 60 mg oral riboflavin · Healthy adults, four males and five females | 60 mg | 1 day | 9 |
| A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status 2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening | 5 mg | 2 years | 103 |
| Riboflavin Supplementation Promotes Butyrate Production in the Absence of Gross Compositional Changes in the Gut Microbiota 2023 · Ribo50 · Healthy adults aged 18–60 years, male and female, with BMI 18–25 kg/m² | 50 mg | 2 weeks | 36 |
| Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study 2021 · Vitamin B2 · Healthy adult volunteers; age and sex range not specified | 75 mg | 4 weeks | 12 |
| The identification and kinetics of 7 alpha-hydroxyriboflavin (7-hydroxymethylriboflavin) in blood plasma from humans following oral administration of riboflavin supplements 1996 · oral 60-mg dose · healthy humans; age and sex not specified | 60 mg | 1 day | — |
| Effect of B vitamins-fortified foods on primary school children in Beijing 2006 · riboflavin supplementation group (+riboflavin) · Normal primary school children aged 9–11 years | 625 mcg | — | 32 |
| Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation 2002 · riboflavin · Elderly adults with EGRAC ≥1.20; mean age 69 years | 1.6 mg | 12 weeks | 23 |
| Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans 1996 · 20 mg oral riboflavin · Healthy adults, four males and five females | 20 mg | 1 day | 9 |
| Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans 1996 · 40 mg oral riboflavin · Healthy adults, four males and five females | 40 mg | 1 day | 9 |
| Riboflavin status in acutely ill patients and response to dietary supplements 2009 · supplement group · hospitalized, acutely ill older patients | 1.3 mg | 6 weeks | — |
| Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults 2016 · 0.2 mg daily riboflavin group · Chinese adult men | 200 mcg | 6 weeks | — |
| Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults 2016 · 0.4 mg daily riboflavin group · Chinese adult men | 400 mcg | 6 weeks | — |
| Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults 2016 · 0.6 mg daily riboflavin group · Chinese adult men | 600 mcg | 6 weeks | — |
| Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults 2016 · 0.8 mg daily riboflavin group · Chinese adult men | 800 mcg | 6 weeks | — |
| Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults 2016 · 1.0 mg daily riboflavin group · Chinese adult men | 1 mg | 6 weeks | — |
| Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people 1998 · 1.6 mg riboflavin · Free-living adults aged 65 years or older; healthy elderly people | 1.6 mg | 12 weeks | — |
| Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people 1998 · 25 mg riboflavin · Free-living adults aged 65 years or older; healthy elderly people | 25 mg | 12 weeks | — |
| Weekly iron supplementation does not block increases in serum zinc due to weekly zinc supplementation in Bangladeshi infants 2005 · 1 mg riboflavin (control) · 6-month-old Bangladeshi infants | 143 mcg | 26 weeks | 82 |
| Impact of the MTHFR C677T polymorphism on one-carbon metabolites: Evidence from a randomised trial of riboflavin supplementation 2020 · riboflavin · Adults with the MTHFR C677T TT genotype | 1.6 mg | 16 weeks | 24 |
| Riboflavin supplementation and biomarkers of cardiovascular disease in the elderly 2009 · Riboflavin group · Men and women aged 60 years or older with low riboflavin status (EGRAC ≥1.2) | 10 mg | 4 weeks | 21 |
| [Mechanism and prevention of hemolysis in jaundiced infants in phototherapy] 1994 · Vit B2 group · Jaundiced newborn infants | 15 mg | — | 18 |
| The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men 2002 · Amitriptyline · Healthy men; age not reported | 30 mg | 2 weeks | 12 |
| Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study 2021 · Vitamin B2 + C · Healthy adult volunteers; age and sex range not specified | 75 mg | 4 weeks | 12 |
| Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status 2002 · Part 1 riboflavin group · Healthy elderly people with sub-optimal riboflavin status | 1.6 mg | 12 weeks | — |
| Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease 2005 · riboflavin · Adults aged 65 years or older with ischemic vascular disease | 25 mg | 1 year | — |
| Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism 2006 · TT genotype riboflavin group · Healthy adults aged 18–65 years with the MTHFR 677 TT genotype | 1.6 mg | 12 weeks | — |
| Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism 2006 · CT genotype riboflavin group · Healthy adults aged 18–65 years with the MTHFR 677 CT genotype | 1.6 mg | 12 weeks | — |
| Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism 2006 · CC genotype riboflavin group · Healthy adults aged 18–65 years with the MTHFR 677 CC genotype | 1.6 mg | 12 weeks | — |
| Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects 2006 · R group · Healthy Japanese men aged 20–29 years | 8.4 mg | 2 weeks | — |
| Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM) 2011 · 2 mg riboflavin · Women aged 19–25 years in the United Kingdom with biochemical riboflavin deficiency (EGRAC >1.40) | 2 mg | 8 weeks | — |
| Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM) 2011 · 4 mg riboflavin · Women aged 19–25 years in the United Kingdom with biochemical riboflavin deficiency (EGRAC >1.40) | 4 mg | 8 weeks | — |
| The identification and kinetics of 7 alpha-hydroxyriboflavin (7-hydroxymethylriboflavin) in blood plasma from humans following oral administration of riboflavin supplements 1996 · oral 20-mg dose · healthy humans; age and sex not specified | 20 mg | 1 day | — |
| The identification and kinetics of 7 alpha-hydroxyriboflavin (7-hydroxymethylriboflavin) in blood plasma from humans following oral administration of riboflavin supplements 1996 · oral 40-mg dose · healthy humans and female patients with liver cirrhosis; age not specified | 40 mg | 1 day | — |
| Riboflavin as an independent and accurate biomarker for adherence in a randomized double-blind and placebo-controlled clinical trial 2017 · placebo group · Premenopausal women aged 30–42 with regular monthly menstrual cycles | 30 mg | 2 years | 98 |
| Riboflavin status in acute ischaemic stroke 2007 · riboflavin and other B-group vitamins · Adults with acute ischaemic stroke | 5 mg | 2 weeks | 37 |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · 20 mg elemental zinc with 1 mg riboflavin · Infants aged 6 months at enrollment, followed until 12 months | 143 mcg | 183 days | — |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception | 1.8 mg | — | 870 |
| Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial 2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies | 500 mcg | 36 weeks | 130 |
| Riboflavin as an independent and accurate biomarker for adherence in a randomized double-blind and placebo-controlled clinical trial 2017 · isoflavone group · Premenopausal women aged 30–42 with regular monthly menstrual cycles | 30 mg | 2 years | 99 |
| Weekly iron supplementation does not block increases in serum zinc due to weekly zinc supplementation in Bangladeshi infants 2005 · 1 mg riboflavin + 20 mg iron and 20 mg zinc · 6-month-old Bangladeshi infants | 143 mcg | 26 weeks | 85 |
| Weekly iron supplementation does not block increases in serum zinc due to weekly zinc supplementation in Bangladeshi infants 2005 · 1 mg riboflavin + 20 mg iron · 6-month-old Bangladeshi infants | 143 mcg | 26 weeks | 83 |
| Assessment of vitamin A, vitamin B(2), vitamin B(12), vitamin K, folate, and choline status following 4 months of multinutrient supplementation in healthy vegans: a randomised, double-blind, placebo-controlled trial 2025 · INT (intervention group; standard and double omega-3 dosage subgroups) · Healthy adults aged 18 years or older who had followed a vegan diet for at least 1 year; no diagnosed vitamin or mineral deficiency | 1.4 mg | 120 days | 35 |
| Effect of B vitamins-fortified foods on primary school children in Beijing 2006 · B vitamin compound supplementation group · Normal primary school children aged 9–11 years | 625 mcg | — | 33 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified | 3.98 mg | 6 weeks | 30 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified | 3.98 mg | 6 weeks | 30 |
| B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke 2004 · B-group vitamin supplements · Patients with acute ischaemic stroke, enrolled within 12 hours of symptom onset; age and sex not specified | 5 mg | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 2 weeks | 24 |
| Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial 2016 · Fortified cereal, morning · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness | 1.71 mg | 12 weeks | 18 |
| Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial 2016 · Fortified cereal, evening · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness | 1.71 mg | 12 weeks | 16 |
| The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men 2002 · St John's wort extract · Healthy men; age not reported | 30 mg | 2 weeks | 12 |
| Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete 2001 · Vitamin B-6 supplementation group · Healthy adults aged 63–80 years; folate- and riboflavin-replete, with no vitamin B-12 deficiency | 1.6 mg | 12 weeks | — |
| Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour 2002 · Folic acid, riboflavin, and vitamin B12 without vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women | 5 mg | 12 weeks | — |
| Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status 2002 · Folic acid and riboflavin group (Part 2, second phase) · Healthy elderly people with sub-optimal riboflavin status | 1.6 mg | 12 weeks | — |
| Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects 2006 · FAR group · Healthy Japanese men aged 20–29 years | 8.4 mg | 2 weeks | — |
| Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy 2007 · Group IV (CoRN for 45 days) · Breast cancer patients undergoing tamoxifen therapy; age and sex not specified | 10 mg | 45 days | — |
| Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy 2007 · Group V (CoRN for 90 days) · Breast cancer patients undergoing tamoxifen therapy; age and sex not specified | 10 mg | 90 days | — |
| Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin 2007 · Group IV (CoRN for 45 days) · Breast cancer patients treated with tamoxifen | 10 mg | 45 days | — |
| Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin 2007 · Group V (CoRN for 90 days) · Breast cancer patients treated with tamoxifen | 10 mg | 90 days | — |
| Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy 2008 · CoRN supplement plus tamoxifen · Breast cancer patients undergoing tamoxifen therapy | 10 mg | — | — |
| Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy 2008 · Group IV (CoRN for 45 days) · Breast cancer patients receiving tamoxifen therapy for more than 1 year; age not reported | 10 mg | 45 days | — |
| Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy 2008 · Group V (CoRN for 90 days) · Breast cancer patients receiving tamoxifen therapy for more than 1 year; age not reported | 10 mg | 90 days | — |
| Supplementation of iron alone and combined with vitamins improves haematological status, erythrocyte membrane fluidity and oxidative stress in anaemic pregnant women 2010 · group IM · Pregnant women with anaemia | 1 mg | 60 days | — |
| Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study 2018 · isoflavone group · Premenopausal women aged 30–42 years with regular monthly menstrual cycles | 30 mg | 2 years | — |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 1.4 mg | 12 weeks | 105 |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · drink powder · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 2.8 mg | 12 weeks | 93 |
| Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial 2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male | 2.4 mg | 60 days | 52 |
| Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour 2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women | 5 mg | 12 weeks | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 7.2 mg | 120 days | — |
| Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial 2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated | 1.3 mg | 6 weeks | — |
| Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial 2024 · intervention group · Critically ill patients with COVID-19 | 4 mg | 2 weeks | 40 |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · 20 mg elemental iron with 1 mg riboflavin · Infants aged 6 months at enrollment, followed until 12 months | 143 mcg | 183 days | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · Control treatment, 1 mg riboflavin only · Infants aged 6 months at enrollment, followed until 12 months | 143 mcg | 183 days | — |